Citation Information :
Pandey A, Kulshrestha R, Menon B, Kumar R, Gaur S. Anthracotic Pigment in Transbronchial Lung Biopsy: An Innocent Bystander or Pathogenic Agent for Parenchymal Lung Disease. Indian J Chest Dis Allied Sci 2018; 60 (1):27-32.
Background: Anthracosis has been recently identified as a cause of bronchitis and bronchial stenosis in both developing and developed countries in the world. However, its exact nature whether as an innocent bystander or pathogenic agent for parenchymal lung disease is unknown.
Methods: We retrospectively analysed 384 transbronchial lung biopsies (TBLBs) received at Department of Pathology over a seven-year period (August 2010 to August 2016). Thirteen TBLBs showed normal lung parenchyma were taken as controls; 32 (8.3%) TBLBs showed deposition of anthracotic pigment, with or without fibrosis and were further studied. Masson-Trichrome and Ziehl-Neelsen stains were used to confirm the diagnosis of fibrosis and tuberculosis, respectively.
Results: The TBLBs were histopathologically categorised into: Group 1 normal lung parenchyma, (controls, n=13, 3.4%); Group 2: pigment deposition with fibrotic parenchymal reaction (n=11, 34.4%); Group 3: pigment deposition with inflammatory parenchymal reaction (n=11, 34.4%); and Group 4: pigment deposition with granulomatous parenchymal reaction (n=10, 31.3%). In two cases of Group 2 and one case of Group 3, parenchymal deposits of silicate crystals were also identified by polarising microscopy.
Conclusions: Anthracosis does not appear to be an innocent bystander and needs to be meticulously assessed for its role as pathogenic agent for parenchymal lung disease in all cases. Our observations suggest that identifying the pigment deposited and correlation with the underlying pathology in the limited tissue sample available can help in reaching a definitive diagnosis.
Dikshtein EA. Changes in the bronchial tree in pneumoconioses combined with bronchogenic cancer. Vopr Onkol 1961;7:20–6.
Petranyi G. Anthracosis in members of the aristocracy and mummies in Hungary. Orv Hetil 1997;138:826.
Fornaciari G. Renaissance mummies in Italy. Med Secoli 1999;11:85–105.
Chung MP, Kyung SL, Han J. Bronchial stenosis due to anthracofibrosis. Chest 1998;113:344–50.
Comert SS, Dogan C, Caglayan B, Fidan A, Kiral N, Salepci B. The demographic, clinical, radiographic and bronchoscopic evaluation of anthracosis and anthracofibrosis cases. J Pulm Respir Med 2012;2:119.
Fekri MS, Lashkarizadeh MR, Kardoost AH, Shokoohi M. Bronchial anthracosis and pulmonary tuberculosis. Tanaffos 2010;9:21–5.
Singh V, Meena H, Bairwa R, Singh S, Sharma BB, Singh A. Clinico-radiological profile and risk factors in patients with anthracosis. Lung India 2015;32:102–6.
Mirsadraee M, Saeedi P. Anthracocis of lung: evaluation of potential underlying causes. Bronchology 2005;12:84–7.
Gómez-Seco J, Pérez-Boal I, Guerrero-González J, Sáez- Noguero F, Fernández-Navamuel I, Rodríguez-Nietoa MJ. Anthracofibrosis or anthracostenosis. Arch Broncopneumol 2012;48:133–6.
Onitilo AA, Engel JM, Tanimu SB, Nguyen TC. Anthracosis and large mediastinal mass in a patient with healed pulmonary tuberculosis. Clin Med Res 2010;8:99–103.
Torres-Duque C, Maldonado D, Pérez-Padilla R, Ezzati M, Viegi G; Forum of International Respiratory Studies (FIRS) Task Force on Health Effects of Biomass Exposure. Biomass fuels and respiratory diseases: a review of the evidence. Proc Am Thorac Soc 2008;5:577–90.
Park HJ, Park SH, Im SA, Kim YK, Lee KY. CT differentiation of anthracofibrosis from endobronchial tuberculosis. AJR Am J Roentgenol 2008;191:247–51.
Kim YJ, Jung CY, Shin HW, Lee BK. Biomass smoke induced bronchial anthracofibrosis: presenting features and clinical course. Respir Med 2009;103:757–65.
Amoli K. Anthracotic airways disease: report of 102 cases. Tanaffos 2009;8:14–22.
Mirsadraee MH, Asnashari AK, Attaran DM. Tuberculosis in patients with anthracosis of lung underlying mechanism or superimposed disease. Iran Red Crescent Med J 2011;13:670–3.
Hwang J, Puttagunta L, Green F, Shimanovsky A, Barrie J, Long R. Bronchial anthracofibrosis and tuberculosis in immigrants to Canada from the Indian subcontinent. Int J Tuberc Lung Dis 2010;14:231–7.
Grobbelaar JP, Beteman ED. Hut lung: a domestically acquired pneumoconiosis of mixed aetiology in rural women. Thorax 1991;46:334–40.
Tanaka M, Satoh M, Kawanami O, Aihara K. A new bronchofiberscope for the study of diseases of very peripheral airways. Chest 1984;85:590–4.
Sandoval J, Salas J, Martinez-Guerra ML, Gomez A, Martinez C, Portales A, et al. Pulmonary arterial hypertension and corpulmonale associated with chronic domestic woodsmoke inhalation. Chest 1993;103:12–20.
Ezzati M, Kammen DM. The health impacts of exposure to indoor air pollution from solid fuels in developing countries: knowledge, gaps, and data needs. Environ Health Perspect 2002;110:1057–68.
Golden EB, Warnock ML, Hulett LD Jr, Churg AM. Fly ash lung: a new pneumoconiosis? Am Rev Respir Dis 1982;125:108–12.
Gold JA, Jagirdar J, Hay JG, Addrizzo-Harris DJ, Naidich DP, Rom WN. Hut lung: a domestically acquired particulate lung disease. Medicine 2000;79:310–7.
Hemmati SH, Shahriar M, Molaei NA. What causes anthracofibrosis? either tuberculosis or smoke. Pak J Med Sci 2008;24:395–8.
Wynn GJ, Turkington PM, O'Driscoll BR. Anthracofibrosis, bronchial stenosis with overlying anthracotic mucosa: possibly a new occupational lung disorder: a series of seven cases from one UK hospital. Chest 2008;134:1069–73.
Allison, AC, Hart PD. Potentiation by silica of the growth of Mycobacterium tuberculosis in macrophage cultures. Br J Exp Pathol 1968;49:465–76.